Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes

Background. Patients with prediabetes are at high risk for diabetes and cardiovascular disease (CVD). No study has explored whether intervention could revert prediabetes to normal glycemic status as the primary outcome. Beijing Prediabetes Reversion Program (BPRP) would evaluate whether intensive li...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yingying, Paul, Sanjoy K., Zhou, Xianghai, Chang, Cuiqing, Chen, Wei, Guo, Xiaohui, Yang, Jinkui, Ji, Linong, Wang, Hongyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266841/
https://www.ncbi.nlm.nih.gov/pubmed/28168204
http://dx.doi.org/10.1155/2017/7602408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266841/
https://www.ncbi.nlm.nih.gov/pubmed/28168204
http://dx.doi.org/10.1155/2017/7602408

Ejemplares similares